Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study



Iroh Tam, Pui-Ying, Chirombo, James, Henrion, Marc, Newberry, Laura, Mambule, Ivan, Everett, Dean, Mwansambo, Charles, Cunliffe, Nigel ORCID: 0000-0002-5449-4988, French, Neil ORCID: 0000-0003-4814-8293, Heyderman, Robert S
et al (show 1 more authors) (2022) Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era: a prospective hospital-based observational study. BMJ Open, 12 (2). e050188-e050188.

This is the latest version of this item.

Access the full-text of this item by clicking on the Open Access link.
[img] Text
Clinical pneumonia in the hospitalised child in Malawi in the post-pneumococcal conjugate vaccine era a prospective hospital.pdf - Published version

Download (315kB) | Preview

Abstract

<jats:sec><jats:title>Objective</jats:title><jats:p>Assess characteristics of clinical pneumonia after introduction of pneumococcal conjugate vaccine (PCV), by HIV exposure status, in children hospitalised in a governmental hospital in Malawi.</jats:p></jats:sec><jats:sec><jats:title>Methods and findings</jats:title><jats:p>We evaluated 1139 children ≤5 years old hospitalised with clinical pneumonia: 101 HIV-exposed, uninfected (HEU) and 1038 HIV-unexposed, uninfected (HUU). Median age was 11 months (IQR 6–20), 59% were male, median mid-upper arm circumference (MUAC) was 14 cm (IQR 13–15) and mean weight-for-height z score was −0.7 (±2.5). The highest Respiratory Index of Severity in Children (RISC) scores were allocated to 10.4% of the overall cohort. Only 45.7% had fever, and 37.2% had at least one danger sign at presentation. The most common clinical features were crackles (54.7%), nasal flaring (53.5%) and lower chest wall indrawing (53.2%). Compared with HUU, HEU children were significantly younger (9 months vs 11 months), with lower mean birth weight (2.8 kg vs 3.0 kg) and MUAC (13.6 cm vs 14.0 cm), had higher prevalence of vomiting (32.7% vs 22.0%), tachypnoea (68.4% vs 49.8%) and highest RISC scores (20.0% vs 9.4%). Five children died (0.4%). However, clinical outcomes were similar for both groups.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>In this post-PCV setting where prevalence of HIV and malnutrition is high, children hospitalised fulfilling the WHO Integrated Management of Childhood Illness criteria for clinical pneumonia present with heterogeneous features. These vary by HIV exposure status but this does not influence either the frequency of danger signs or mortality. The poor performance of available severity scores in this population and the absence of more specific diagnostics hinder appropriate antimicrobial stewardship and the rational application of other interventions.</jats:p></jats:sec>

Item Type: Article
Uncontrolled Keywords: epidemiology, paediatric infectious disease & immunisation, respiratory infections
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 10 Jun 2022 14:00
Last Modified: 18 Jan 2023 21:00
DOI: 10.1136/bmjopen-2021-050188
Open Access URL: https://bmjopen.bmj.com/content/12/2/e050188
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3156181

Available Versions of this Item